ISRCTN39643421已完成不适用
Trial of Short Course Therapy in Elderly Patients with High Grade Non-Hodgkin's Lymphoma
K Co-ordinating Committee for Cancer Research (UKCCCR)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Aged 60 to 85 years
- •2. Newly presenting high grade lymphoma presenting as:
- •2.1 Follicular lymphoma
- •2.2 Diffuse large cell lymphoma including immunoblastic
- •2.3 Diffuse mixed cell lymphoma - Lymphoblastic and Burkitt's lymphoma are excluded
- •3. Stage IB-IV
- •4. Patients must be free from any other irreversible medical condition that would drastically limit their lifespan or prohibit the use of combination chemotherapy
排除标准
- •Not provided at time of registration
研究者
相似试验
尚未招募
不适用
Prospective study of treatment for elderly patients with PAD (peripheral arterial disease) using Propensity Score Analysisperipheral arterial diseaseJPRN-UMIN000013630Hakodate cardiovascular disease round-table conference2,000
进行中（未招募）
1 期
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by Thalidomide maintenance versus MP-Lenalidomide (MP-Len) follwed by maintenance with Lenalidomide.Multiple MyelomaEUCTR2007-004007-34-SEHOVON Foundation668
已完成
3 期
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by thalidomide maintenance versus MP-Lenalidomide (MP-Len) followed by maintenance with lenalidomideKahlers disease10035227Multiple MyelomaNL-OMON50624HOVO500
进行中（未招募）
1 期
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by thalidomide maintenance versus MP-Lenalidomide (MP-Len) followed by maintenance with lenalidomide - HOVON 87 MMMedDRA version: 14.1Level: PTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Multiple MyelomaEUCTR2007-004007-34-DKHOVON Foundation668
进行中（未招募）
1 期
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by thalidomide maintenance versus MP-Lenalidomide (MP-Len) followed by maintenance with lenalidomideMedDRA version: 21.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864Multiple MyelomaEUCTR2007-004007-34-NLHOVON Foundation668